| Publications |
|
Kroczynska, B.; Kaur, S.; Platanias, L
Growth suppressive cytokines and the AKT/mTOR pathway.
Cytokine
(2009)
48:138-143.
|
|
Guerrouahen, B. S.; Wieder, E.; Blanchard, E. G.; Lee, F. Y.; Aplenc, R.; Corey, S
Flow cytometric determination of Src phosphorylation in pediatric patients treated with dasatinib.
Pediatr Blood Cancer
(2009)
53:1132-1135.
|
|
Feng, Y.; Hartig, S. M.; Bechill, J. E.; Blanchard, E. G.; Caudell, E.; Corey, S
The Cdc42 interacting protein 4 (CIP4) gene knockout mouse reveals delayed and decreased endocytosis.
J Biol Chem
(2009)
In process.
|
|
Chen, H.; Pazicni, S.; Krett, NL; Ahn, R. W.; Penner-Hahn, J. E.; Rosen, ST; O'Halloran, TV
Coencapsulation of Arsenic- and Platinum-based Drugs for Targeted Cancer Treatment.
Angew Chem Int Ed Engl
(2009)
48:9295-9299.
|
|
Eklund, E; Platanias, L
Screening for microRNAs in myelodysplastic syndromes.
Leuk Lymphoma
(2009)
50:1735-1736.
|
|
Unno, K.; Zhou, Y.; Zimmerman, T.; Platanias, L; Wickrema, A.
Identification of a novel microRNA cluster miR-193b-365 in multiple myeloma.
Leuk Lymphoma
(2009)
50:1865-1871.
|
|
Umetsu, S. E.; Winandy, S
Ikaros Is a Regulator of Il10 Expression in CD4+ T Cells.
J Immunol
(2009)
183:5518-5525.
|
|
Fenske, T. S.; Hari, P. N.; Carreras, J.; Zhang, M. J.; Kamble, R. T.; Bolwell, B. J.; Cairo, M. S.; Champlin, R. E.; Chen, Y. B.; Freytes, C. O.; Gale, R. P.; Hale, G. A.; Ilhan, O.; Khoury, H. J.; Lister, J.; Maharaj, D.; Marks, D. I.; Munker, R.; Pecora, A. L.; Rowlings, P. A.; Shea, T. C.; Stiff, P.; Wiernik, P. H.; Winter, JN; Rizzo, J. D.; van Besien, K.; Lazarus, H. M.; Vose, J. M.
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.
Biol Blood Marrow Transplant
(2009)
15:1455-1464.
|
|
Aguilera, D. G.; Vaklavas, C.; Tsimberidou, A. M.; Wen, S.; Medeiros, L. J.; Corey, S
Pediatric Therapy-related Myelodysplastic Syndrome/Acute Myeloid Leukemia: The MD Anderson Cancer Center Experience.
J Pediatr Hematol Oncol
(2009)
31:803-811.
|
|
Giammona, L. M.; Panuganti, S.; Kemper, J. M.; Apostolidis, P. A.; Lindsey, S.; Papoutsakis, E. T.; Miller, WM
Mechanistic Studies on the Effects of Nicotinamide on Megakaryocytic Polyploidization and the roles of NAD(+) levels and SIRT inhibition.
Exp Hematol
(2009)
37:1340-1352.e3.
|
|
Shanmugam, M.; McBrayer, S. K.; Rosen, ST
Targeting the Warburg effect in hematological malignancies: from PET to therapy.
Curr Opin Oncol
(2009)
21:531-536.
|
|
Rice, K. L.; Hormaeche, I.; Doulatov, S.; Flatow, J. M.; Grimwade, D.; Mills, K. I.; Leiva, M.; Ablain, J.; Ambardekar, C.; McConnell, M. J.; Dick, J. E.; Licht, J
Comprehensive genomic screens identify a role for PLZF-RAR{alpha} as a positive regulator of cell proliferation via direct regulation of c-MYC.
Blood
(2009)
In process.
|
|
Mehta, J
Re: Tandem vs Single Autologous Hematopoietic Cell Transplantation for the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis.
J Natl Cancer Inst
(2009)
101:1430-1; author reply 1431.
|
|
Bieging, K. T.; Amick, A. C.; Longnecker, RM
Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.
Proc Natl Acad Sci U S A
(2009)
106:17945-17950.
|
|
Evens, A; Spies, W. G.; Helenowski, I. B.; Patton, D.; Spies, S.; Jovanovic, B. D.; Miyata, S.; Hamilton, E.; Variakojis, D.; Chen, J.; Naumovski, L.; Rosen, ST; Winter, JN; Miller, RJ; Gordon, LI
The Novel Expanded Porphyrin, Motexafin Gadolinium, Combined with [90Y]Ibritumomab Tiuxetan for Relapsed/Refractory Non-Hodgkin's Lymphoma: Preclinical Findings and Results of a Phase I Trial.
Clin Cancer Res
(2009)
15:6462-6471.
|
|
Figueroa, M. E.; Skrabanek, L.; Li, Y.; Jiemjit, A.; Fandy, T. E.; Paietta, E.; Fernandez, H.; Tallman, MS; Greally, J. M.; Carraway, H.; Licht, J; Gore, S. D.; Melnick, A.
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation.
Blood
(2009)
114:3448-3458.
|
|
Marks, D. I.; Paietta, E. M.; Moorman, A. V.; Richards, S. M.; Buck, G.; Dewald, G.; Ferrando, A.; Fielding, A. K.; Goldstone, A. H.; Ketterling, R. P.; Litzow, M. R.; Luger, S. M.; McMillan, A. K.; Mansour, M.; Rowe, J. M.; Tallman, MS; Lazarus, H. M.
T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics and outcome from the large randomised prospective trial (UKALL XII/ECOG 2993).
Blood
(2009)
In process.
|
|
Querfeld, C.; Mehta, N.; Rosen, ST; Guitart, J; Rademaker, AW; Gerami, P; Kuzel, TM
Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer Center.
Leuk Lymphoma
(2009)
In process.
|
|
Litzow, M. R.; Othus, M.; Cripe, L. D.; Gore, S. D.; Lazarus, H. M.; Lee, S. J.; Bennett, J. M.; Paietta, E. M.; Dewald, G. W.; Rowe, J. M.; Tallman, MS
Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group.
Br J Haematol
(2009)
In process.
|
|
Chen, Y. H.; Gao, J.; Fan, G.; Peterson, LC
Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms.
Mod Pathol
(2009)
In process.
|
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract.
.
.
.
